Literature DB >> 3171622

Cerebellar ataxia with recovery related to central pontine myelinolysis.

U Steller1, F Koschorek, H Strenge.   

Abstract

Development of severe ataxia and mild pyramidal signs without mental deterioration, tetraparesis or pseudobulbar palsy during recovery from withdrawal delirium and initial hyponatraemia are unusual clinical features consistent with central pontine myelinolysis. This diagnosis was confirmed by magnetic resonance imaging (MRI) in an alcoholic man. Clinical and electrodiagnostic improvement occurred, whereas the MRI findings remained unchanged in a follow-up study.

Entities:  

Mesh:

Year:  1988        PMID: 3171622     DOI: 10.1007/bf00314240

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients.

Authors:  R D ADAMS; M VICTOR; E L MANCALL
Journal:  AMA Arch Neurol Psychiatry       Date:  1959-02

2.  Central pontine myelinolysis: report of a case with distinctive appearance on MR imaging.

Authors:  D B Price; J Kramer; G C Hotson; J P Loh
Journal:  AJNR Am J Neuroradiol       Date:  1987 May-Jun       Impact factor: 3.825

3.  [Central pontine myelinolysis in alcoholism. Clinical aspects, neurophysiology, computerized tomography and nuclear magnetic resonance tomography in a patient who survived].

Authors:  J Haan; A Deppe
Journal:  Nervenarzt       Date:  1986-10       Impact factor: 1.214

4.  Pontine and extrapontine myelinolysis.

Authors:  D G Wright; R Laureno; M Victor
Journal:  Brain       Date:  1979-06       Impact factor: 13.501

5.  Clinical and CT confirmed recovery from central pontine myelinolysis.

Authors:  G Schroth
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

6.  Central pontine myelinolysis: demonstration by nuclear magnetic resonance.

Authors:  L D DeWitt; F S Buonanno; J P Kistler; T Zeffiro; R L DeLaPaz; T J Brady; B R Rosen; I L Pykett
Journal:  Neurology       Date:  1984-05       Impact factor: 9.910

7.  Association between rise in serum sodium and central pontine myelinolysis.

Authors:  M D Norenberg; K O Leslie; A S Robertson
Journal:  Ann Neurol       Date:  1982-02       Impact factor: 10.422

8.  MR imaging of central pontine myelinolysis.

Authors:  D J Rippe; M K Edwards; P G D'Amour; R W Holden; K L Roos
Journal:  J Comput Assist Tomogr       Date:  1987 Jul-Aug       Impact factor: 1.826

9.  Pontine ataxic hemiparesis studied by a high-resolution magnetic resonance imaging system.

Authors:  H Nabatame; H Fukuyama; I Akiguchi; M Kameyama; K Nishimura; K Torizuka
Journal:  Ann Neurol       Date:  1987-02       Impact factor: 10.422

10.  Central pontine myelinolysis. A clinical reappraisal.

Authors:  W C Wiederholt; M K Kobayashi; J J Stockard; V S Rossiter
Journal:  Arch Neurol       Date:  1977-04
View more
  5 in total

1.  Magnetic resonance imaging in central pontine myelinolysis.

Authors:  P D Thompson; D Miller; R F Gledhill; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

2.  Marchiafava-Bignami disease with recovery diagnosed by CT and MRI: demyelination affects several CNS structures.

Authors:  R Baron; K Heuser; G Marioth
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

3.  Cerebellar ataxia with complete clinical recovery and resolution of MRI lesions related to central pontine myelinolysis: case report and literature review.

Authors:  Cristina Dolciotti; Angelo Nuti; Gabriele Cipriani; Paolo Borelli; Filippo Baldacci; Chiara Logi; Ubaldo Bonuccelli
Journal:  Case Rep Neurol       Date:  2010-12-22

4.  Regressive dystonia and cerebellar ataxia: two unusual symptoms in central pontine myelinolysis.

Authors:  L Defebvre; P Rogelet; A Destée; A Verier
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

5.  Reversible Cerebellar Ataxia Related to Extrapontine Myelinolysis without Hyponatremia after Cisplatin-Based Chemotherapy for Cholangiocarcinoma.

Authors:  Jae Heun Chung; Seung Kug Baik; Su-Hee Cho; Seong-Geun Kim
Journal:  Cancer Res Treat       Date:  2014-09-11       Impact factor: 4.679

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.